Recursion Pharmaceuticals Price Target Maintained With a $11.00/Share by Needham

Needham维持Recursion Pharmaceuticals的股价目标为每股11.00美元

道琼斯 · 11/20 12:43 · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.